Lisata Therapeutics, Inc.
LSTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $24,820 | $22,039 | $13,105 | $46,469 |
| - Cash | $16,209 | $22,593 | $32,154 | $24,647 |
| + Debt | $137 | $305 | $485 | $714 |
| Enterprise Value | $8,748 | -$249 | -$18,564 | $22,536 |
| Revenue | $1,000 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1,000 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$22,235 | -$25,519 | -$57,532 | -$28,995 |
| % Margin | -2,223.5% | – | – | – |
| Net Income | -$19,985 | -$20,840 | -$54,225 | -$27,466 |
| % Margin | -1,998.5% | – | – | – |
| EPS Diluted | -2.4 | -2.58 | -10.47 | -7.45 |
| % Growth | 7% | 75.4% | -40.5% | – |
| Operating Cash Flow | -$19,356 | -$20,032 | -$21,170 | -$22,245 |
| Capital Expenditures | $0 | $0 | -$285 | -$60 |
| Free Cash Flow | -$19,356 | -$20,032 | -$21,455 | -$22,305 |